Evidence map›Paper›PMID 30294617›Full record

ArticleOpen forum infectious diseases2018

Infectious MERS-CoV Isolated From a Mildly Ill Patient, Saudi Arabia.

Hail M Al-Abdely, Claire M Midgley, Abdulrahim M Alkhamis, Glen R Abedi, Azaibi Tamin, Alison M Binder, Khalid Alanazi, Xiaoyan Lu, Osman Abdalla, Senthilkumar K Sakthivel and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Hail M Al-AbdelyMinistry of Health, Riyadh, Saudi Arabia.
Claire M MidgleyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abdulrahim M AlkhamisMinistry of Health, Riyadh, Saudi Arabia.
Glen R AbediDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Azaibi TaminDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-9726-8940
Alison M BinderDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Khalid AlanaziMinistry of Health, Riyadh, Saudi Arabia.
Xiaoyan LuDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Osman AbdallaMinistry of Health, Riyadh, Saudi Arabia.
Senthilkumar K SakthivelDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mutaz MohammedMinistry of Health, Riyadh, Saudi Arabia.
Krista QueenDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Homoud S AlgarniMinistry of Health, Riyadh, Saudi Arabia.
Yan LiDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Suvang TrivediDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abdullah AlgwizaniPrince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
Raafat F AlhakeemMinistry of Health, Riyadh, Saudi Arabia.
Natalie J ThornburgDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0003-3523-3616
Suxiang TongDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sameeh S GhazalPrince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
Dean D ErdmanDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abdullah M AssiriMinistry of Health, Riyadh, Saudi Arabia.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
John T WatsonDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with a wide range of clinical presentations, from asymptomatic or mildly ill to severe respiratory illness including death. We describe isolation of infectious MERS-CoV from the upper respiratory tract of a mildly ill 27-year-old female in Saudi Arabia 15 days after illness onset.

Indexed as

asymptomaticMERSmildprolonged detectionvirus isolation

Identifiers

PMID30294617
PMCPMC6016420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.